CELGENE CORPORATION for CELGENE CORPORATION
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
coding related to wound care products
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALAN EISENBERG | Congressional Staff, Rep. Greenwood, 2001-2004 |
Copyright/Patent/Trademark CPT
patent issues in China; patent issues in Canada; issues related to the Patent Trial and Appeal Board (United States Patent & Trademark Office); proposed rules related to patent term adjustment (United States Patent & Trademark Office); implementation of patent linkage mechanisms (Republic of Korea)
| Lobbyist | Covered position, as disclosed |
|---|---|
| RICHARD T GIRARDS | — |
Health Issues HCR
REMS proposals, including Stivers-Welch (H.R. 5657); MODDERN Cures Act (H.R. 3116); oral parity (H.R. 1801); specialty tier/cost sharing (H.R. 460); proposed orphan drug policies; other issues related to dormant therapies, including proposed legislation to expand incentives
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALAN EISENBERG | Congressional Staff, Rep. Greenwood, 2001-2004 |
| RICHARD T GIRARDS | — |
| PATRICK GLIHA | — |
| MATTHEW SCHUMAKER New | — |
Trade (domestic/foreign) TRD
Turkey: exchange rate issues; negotiation of IP-related and other provisions of the Trans-Pacific Partnership; negotiation of IP-related and other provisions of the Transatlantic Trade & Investment Partnership
| Lobbyist | Covered position, as disclosed |
|---|---|
| RICHARD T GIRARDS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.